Electromedical Technologies Files 8-K with Corporate Updates
Ticker: EMED · Form: 8-K · Filed: Jul 24, 2024 · CIK: 1715819
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
ETMC filed an 8-K on July 18th for corporate updates, including bylaw changes. Keep an eye on this.
AI Summary
Electromedical Technologies, Inc. filed an 8-K on July 24, 2024, reporting events as of July 18, 2024. The filing indicates amendments to its Articles of Incorporation or Bylaws and includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing signals potential changes in the company's corporate structure or governance, which could impact its operational direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediate negative financial or operational news.
Key Players & Entities
- Electromedical Technologies, Inc. (company) — Registrant
- July 18, 2024 (date) — Earliest event reported
- July 24, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text.
What is the nature of the financial statements and exhibits included with this filing?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When is Electromedical Technologies, Inc.'s fiscal year end?
The company's fiscal year ends on December 31.
What is the principal executive office address for Electromedical Technologies, Inc.?
The principal executive offices are located at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260.
What is the issuer's telephone number?
The issuer's telephone number is 888-880-7888.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-07-24 16:01:35
Key Financial Figures
- $0.00001 — 000,000,000) shares with a par value of $0.00001 per share. Series "A" Preferred Shares
Filing Documents
- tm2420032d1_8k.htm (8-K) — 27KB
- tm2420032d1_ex3-1.htm (EX-3.1) — 3KB
- tm2420032d1_ex3-1img01.jpg (GRAPHIC) — 110KB
- 0001104659-24-082325.txt ( ) — 356KB
- elcq-20240718.xsd (EX-101.SCH) — 3KB
- elcq-20240718_lab.xml (EX-101.LAB) — 33KB
- elcq-20240718_pre.xml (EX-101.PRE) — 22KB
- tm2420032d1_8k_htm.xml (XML) — 4KB
03 - Amendments to Articles of Incorporation or Bylaws; Change
Item 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On July 18, 2024, the Board of Directors approved by resolution, and a majority of the shareholders eligible to vote approved by written consent, an amendment to Section 4 of the Corporation's Certificate of Incorporation. This amendment increases the total number of authorized shares to three billion, one million, and one share. The details are as follows: Fourth: The aggregate number of shares that the Corporation is authorized to issue is Three Billion, One Million, and One (3,001,000,001), which includes: Common Stock: Three Billion (3,000,000,000) shares with a par value of $0.00001 per share. Series "A" Preferred Shares: One Million (1,000,000) shares with a par value of $0.00001 per share; and Series "B" Preferred Shares: One (1) share with a par value of $0.00001 per share. The Certificate of Amendment is being processed by the Delaware Secretary of State and will be effective upon completion of the filing. Section 9 – Financial Statement and Exhibits
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits Exhibit No. Document Location 3.1 Certificate of Amendment Filed Herewith 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated July 24, 2024 ELECTROMEDICAL TECHNOLOGIES, INC. By: /s/ Matthew Wolfson Matthew Wolfson Chief Executive Officer (Principal Executive Officer)